Tools & Resources
- MS Diagnosis: Where to Begin
- Fight MS Flare-Ups
- MS vs. ALS
- Celebrities With MS
- Alternative MS Therapies
- Botulinum Toxin for Muscle Pain
NewsRelated to Multiple Sclerosis
- New Drug May Slow MS Progression
April 12, 2011 -- The experimental oral multiple sclerosis (MS) drug laquinimod delayed disease progression, reduced relapse rates, and was safe and well tolerated by patients in a two-year study. Details of the study were announced Monday by the drug’s developer, Teva Pharmaceutical Industries, at
Read Full Article - Medical Marijuana May Impair Thinking of MS Patients
March 28, 2011 -- Many multiple sclerosis (MS) patients use marijuana to ease pain and other symptoms associated with the disorder, but the practice might make one common symptom worse. MS patients in a small study who smoked or ingested marijuana regularly for many years were twice as likely as non
Read Full Article - Stem Cell Transplants May Treat Aggressive MS
March 21, 2011 -- Replacing bone marrow with the body’s own stem cells may help patients with aggressive forms of multiple sclerosis (MS) go for years without seeing their disease progress, a new study shows. Researchers in Greece are following a group of 35 patients who received experimental stem c
Read Full Article - Hot Weather Worsens Memory in MS Patients
Feb. 17, 2011 -- As one of the most brutally cold winters on record drags on, most of us are pining for summer. But for many patients with multiple sclerosis, hotter temperatures may not be so welcome because they bring worsening symptoms. Now new research finds this may be especially true for some
Read Full Article - Sun Exposure, Vitamin D May Lower MS Risk
Feb. 7, 2011 -- Higher vitamin D levels and exposure to sunlight appear to be independently protective against multiple sclerosis, a progressive autoimmune disease that affects around 400,000 Americans. In a newly published study from Australia that included people with and without early signs of mu
Read Full Article - Guidelines Recommend Plasma Exchange for MS
Jan. 19, 2011 -- Updated guidelines from the American Academy of Neurology recommend plasma exchange (plasmapheresis) for the treatment of certain types of multiple sclerosis (MS) and other inflammatory neurological conditions, including Guillain-Barré syndrome and CIDP (chronic inflammatory demyeli
Read Full Article - Women With MS More Likely to Have Gene Mutation
Jan 5, 2011 -- New research may help explain why multiple sclerosis rates have risen sharply in the U.S. and some other countries among women, while rates appear stable in men. The study could also broaden understanding of how environmental influences alter genes to cause a wide range of diseases. T
Read Full Article - Mindfulness Meditation vs. Multiple Sclerosis
Sept. 27, 2010 -- Learning a mind-body technique called “mindfulness meditation” seems to help people with multiple sclerosis cope with the depression, fatigue, and anxiety associated with the disease, a new study indicates. Researchers in Switzerland signed up 150 people with mild to moderate multi
Read Full Article - Gilenya, First Oral MS Drug, Gets FDA Nod
Sept. 22, 2010 -- The FDA today approved Novartis' Gilenya, the first oral drug for multiple sclerosis (MS). Gilenya (formerly spelled Gilenia, generic name fingolimod) last June received the overwhelming approval of an FDA expert advisory panel. Gilenya treats the relapsing form of MS. The drug sig
Read Full Article - Asthma Drug Albuterol May Help Treat MS
Sept. 13, 2010 -- Adding the asthma drug albuterol to a treatment for multiple sclerosis (MS) improved walking ability and delayed the time to first relapse among patients in a newly published study. Patients starting daily injections of the MS drug glatiramer acetate -- known by the brand name Copa
Read Full Article
Displaying 61 - 70of 221 Articles<<Prev Page34567 89101112Next>>